Therapeutic drug monitoring of isoniazid, rifampin, and pyrazinamide in HIV-infected patients with tuberculosis

被引：0
|
作者：
Baniasadi, Shadi [1 ]
Fahimi, Fanak [2 ]
Tabarsi, Payam [2 ]
Nadji, Seyed Alireza [1 ]
Khabiri, Shadi [2 ]
Shahsavari, Nahid [3 ]
Kobarfard, Farzad [3 ]
机构：
[1] Natonal Res Inst TB & Lung Dis, Virol Res Ctr, Tehran, Iran
[2] Natonal Res Inst TB & Lung Dis, Chron Resp Dis Res Ctr, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Med Chem Dept, Sch Pharm, Tehran, Iran
来源：
EUROPEAN RESPIRATORY JOURNAL | 2012年 / 40卷
关键词：
Pharmacology; Infections; Treatments;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
2959
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months
    Nolan, CM
    Goldberg, SV
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2002, 6 (11) : 952 - 958
  • [32] Novel approach to therapeutic drug monitoring of nevirapine in pediatric HIV-infected patients.
    Rakhmanina, N
    van den Anker, J
    Spiegel, H
    Sever, J
    Soldin, S
    JOURNAL OF INVESTIGATIVE MEDICINE, 2005, 53 (02) : S401 - S401
  • [33] Hepatotoxicity of rifampin-pyrazinamide and isoniazid preventive therapy and tuberculosis treatment
    van Hest, R
    Baars, H
    Kik, S
    van Gerven, P
    Trompenaars, MC
    Kalisvaart, N
    Keizer, S
    Borgdorff, M
    Mensen, M
    Cobelens, F
    CLINICAL INFECTIOUS DISEASES, 2004, 39 (04) : 488 - 496
  • [34] STABILITY OF ISONIAZID, RIFAMPIN AND PYRAZINAMIDE IN SUSPENSIONS USED FOR THE TREATMENT OF TUBERCULOSIS IN CHILDREN
    SEIFART, HI
    PARKIN, DP
    DONALD, PR
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1991, 10 (11) : 827 - 831
  • [35] Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana. (vol 48, pg 1685, 2009)
    Chideya, S.
    Winston, C. A.
    Peloquin, C. A.
    CLINICAL INFECTIOUS DISEASES, 2009, 49 (05)
  • [36] Clinical update: Impact of HIV protease inhibitors on the treatment of HIV-infected tuberculosis patients with rifampin (Reprinted)
    不详
    ANNALS OF PHARMACOTHERAPY, 1997, 31 (03) : 387 - 387
  • [37] COST EFFECTIVENESS ANALYSIS TO TREAT LATENT TUBERCULOSIS INFECTION: CAMPARING ISONIAZID, RIFAMPIN AND RIFAMPIN/PYRAZINAMIDE
    Sangani, D.
    VALUE IN HEALTH, 2010, 13 (03) : A191 - A191
  • [38] Therapeutic drug monitoring of rifampicin, isoniazid, and pyrazinamide in newly-diagnosed pulmonary tuberculosis outpatients in Denpasar area
    Widhiartini, Ida Ayu Alit
    Wirasuta, I. Made Agus Gelgel
    Sukrama, Dewa Made
    Rai, Ida Bagus Ngurah
    BALI MEDICAL JOURNAL, 2019, 8 (01) : 107 - 113
  • [39] Isoniazid, Rifampin, and Pyrazinamide Plasma Concentrations in Relation to Treatment Response in Indonesian Pulmonary Tuberculosis Patients
    Burhan, Erlina
    Ruesen, Carolien
    Ruslami, Rovina
    Ginanjar, Arum
    Mangunnegoro, Hadiarto
    Ascobat, Purwantyastuti
    Donders, Rogier
    van Crevel, Reinout
    Aarnoutse, Rob
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (08) : 3614 - 3619
  • [40] Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis
    Schaberg, T
    Rebhan, K
    Lode, H
    EUROPEAN RESPIRATORY JOURNAL, 1996, 9 (10) : 2026 - 2030
12345